117.63 USD
-1.18 (-0.99%)
119.49 USD
+1.86 (+1.58%)
We assign a fundamental rating of 2 out of 10 to RVMD. RVMD was compared to 525 industry peers in the Biotechnology industry. While RVMD seems to be doing ok healthwise, there are quite some concerns on its profitability. RVMD is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- RVMD had negative earnings in the past year.
- In the past year RVMD has reported a negative cash flow from operations.
- RVMD had negative earnings in each of the past 5 years.
- In the past 5 years RVMD always reported negative operating cash flow.
1.2 Ratios
- RVMD's Return On Assets of -26.65% is fine compared to the rest of the industry. RVMD outperforms 69.71% of its industry peers.
- The Return On Equity of RVMD (-37.58%) is better than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.65% | ||
| ROE | -37.58% | ||
| ROIC | N/A |
ROA(3y)-25.08%
ROA(5y)-24.01%
ROE(3y)-28.89%
ROE(5y)-28.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RVMD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RVMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- RVMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, RVMD has more shares outstanding
- RVMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 19.39 indicates that RVMD is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 19.39, RVMD belongs to the top of the industry, outperforming 88.38% of the companies in the same industry.
- A Debt/Equity ratio of 0.16 indicates that RVMD is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.16, RVMD is doing worse than 64.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 19.39 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 8.05 indicates that RVMD has no problem at all paying its short term obligations.
- With a decent Current ratio value of 8.05, RVMD is doing good in the industry, outperforming 74.67% of the companies in the same industry.
- A Quick Ratio of 8.05 indicates that RVMD has no problem at all paying its short term obligations.
- The Quick ratio of RVMD (8.05) is better than 74.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.05 | ||
| Quick Ratio | 8.05 |
3. Growth
3.1 Past
- The earnings per share for RVMD have decreased strongly by -44.01% in the last year.
- RVMD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)-44.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.28%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, RVMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.31% on average per year.
- Based on estimates for the next years, RVMD will show a very strong growth in Revenue. The Revenue will grow by 456.14% on average per year.
EPS Next Y-59.96%
EPS Next 2Y-35.33%
EPS Next 3Y-18.97%
EPS Next 5Y14.31%
Revenue Next Year1279.08%
Revenue Next 2Y959.89%
Revenue Next 3Y784.17%
Revenue Next 5Y456.14%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- RVMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year RVMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- RVMD's earnings are expected to decrease with -18.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-35.33%
EPS Next 3Y-18.97%
5. Dividend
5.1 Amount
- RVMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
REVOLUTION MEDICINES INC / RVMD FAQ
What is the ChartMill fundamental rating of REVOLUTION MEDICINES INC (RVMD) stock?
ChartMill assigns a fundamental rating of 2 / 10 to RVMD.
What is the valuation status for RVMD stock?
ChartMill assigns a valuation rating of 0 / 10 to REVOLUTION MEDICINES INC (RVMD). This can be considered as Overvalued.
How profitable is REVOLUTION MEDICINES INC (RVMD) stock?
REVOLUTION MEDICINES INC (RVMD) has a profitability rating of 1 / 10.
How financially healthy is REVOLUTION MEDICINES INC?
The financial health rating of REVOLUTION MEDICINES INC (RVMD) is 5 / 10.
What is the expected EPS growth for REVOLUTION MEDICINES INC (RVMD) stock?
The Earnings per Share (EPS) of REVOLUTION MEDICINES INC (RVMD) is expected to decline by -59.96% in the next year.